
Platepag ML 25mg Tablet
Marketer
Metta Life Sciences Private Limited
Salt Composition
Eltrombopag (25mg)
Overview Platepag ML 25mg Tablet
Eltrombopag 25mg tablets are indicated for the management of low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP) or persistent hepatitis C virus (HCV) infection. This medication also addresses severe aplastic anemia. Acting as a thrombopoietin receptor agonist, eltrombopag boosts platelet production. Platelets are crucial for hemostasis. Adhere strictly to your physician's prescribed dosage and regimen. Administration on an empty stomach is acceptable. Swallow the tablet whole; do not crush, chew, or break it. Report any known drug allergies to your doctor. Commonly reported adverse effects include nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Discuss any bothersome side effects with your doctor; management strategies may be available. Prior to commencing treatment, disclose any pre-existing health issues and all concurrent medications. Dosage modifications might be necessary for individuals with hepatic impairment; consult your doctor.
Uses of Platepag ML 25mg Tablet
Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; Management of critical bone marrow failure
Major Benefits of Platepag ML 25mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Platepag ML 25mg Tablet on an empty stomach.
Common Side effects of Platepag ML 25mg Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Platepag ML 25mg Tablet:
Your physician will determine the correct dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Platepag ML 25mg Tablets should be taken on an empty stomach.
How Platepag ML 25mg Tablet works:
The thrombocytopenia medication Platepag ML 25mg Tablet acts as a thrombopoietin receptor activator, boosting platelet production within the bloodstream. This increase in platelets aids in minimizing or preventing hemorrhaging.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Platepag ML 25mg Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Platepag ML 25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Administering Platepag ML 25mg tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Platepag ML 25mg Tablet, which can induce dizziness and other side effects that reduce alertness.
KidneySAFE IF PRESCRIBED
The use of Platepag ML 25mg Tablet is considered safe for individuals with kidney impairment; dosage modification is typically unnecessary. Nevertheless, disclosure of kidney disease to your physician is recommended. Routine monitoring of kidney function is advised during treatment with this medication.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Platepag ML 25mg Tablets. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Platepag ML 25mg Tablet :
Omit any missed dose of Platepag ML 25mg Tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Platepag ML 25mg Tablet
Label | Value |
---|---|
Chemical Category | Biphenyl Derivatives |
Developing Habits | No. |
Type of Therapy | KINSHIP |
Active Class | Thrombopoietin receptor activator |